Relay Therapeutics (RLAY) Shares Issued (2019 - 2025)

Relay Therapeutics (RLAY) has 7 years of Shares Issued data on file, last reported at $9.3 million in Q4 2025.

• On a quarterly basis, Shares Issued rose 499.47% year-over-year to $9.3 million in Q4 2025; TTM through Dec 2025 was $9.3 million, a 499.47% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 499.47% from the prior year.
• Shares Issued for Q4 2025 stood at $9.3 million, up from $1.6 million in the prior quarter.
• Over the last five years, Shares Issued for RLAY reached as high as $12.4 million in Q4 2023 and fell as low as $1.6 million in Q4 2024.
• Historically, Shares Issued has averaged $5.4 million across 5 years, with a median of $1.8 million in 2021.
• Across the five-year window, Shares Issued surged 598.45% in 2023 and slumped 87.44% in 2024, its largest moves.
• Year by year, Shares Issued stood at $1.8 million in 2021, then dropped by 2.16% to $1.8 million in 2022, then jumped by 598.45% to $12.4 million in 2023, then slumped by 87.44% to $1.6 million in 2024, then surged by 499.47% to $9.3 million in 2025.
• Per Business Quant data, the three most recent Shares Issued figures were $9.3 million in Q4 2025, $1.6 million in Q4 2024, and $12.4 million in Q4 2023.